Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.
Source: https://pixabay.com/en/white-blood-cell-cell-blood-cell-543471/
In Jordyn Sava's reporting from Targeted Oncology, readers learn that the U.S. Food and Drug Administration (FDA) granted clearance to a global Phase 3 study. This means that the…
Continue Reading
FDA Clears Global Phase 3 Study of Lisaftoclax for Previously Treated CLL or SLL
Unfortunately, gaining access to care within the rare disease space can be difficult. There is often lesser education and awareness about rare conditions, less research performed, and poorer access to…
Continue Reading
China Expands Medical Insurance Coverage to Improve Access and Affordability for Rare Disease Drugs
21-year-old Chloe Feighery has a deep love and appreciation for her younger sister Heidi, who is just one and a half years old. When she learned that she was becoming…
Continue Reading
Woman Abseils Down Croke Park to Raise Funds and Awareness for Vici Syndrome
Source: Pixabay
Soon after Emma Young was born, she was diagnosed with a rare genetic disorder called Bannayan-Riley-Ruvalcaba syndrome (BRRS). At two months old, she battled COVID-19. Then she was diagnosed with…
Continue Reading
Paws for Emma: This Family Needs a Service Dog for Daughter with BRRS
source: shutterstock.com
For the first year of his life, Warner Kays looked like an average, healthy, happy baby. He crawled around, took joy in family time with his older sister Presley, and…
Continue Reading
Warriors for Warner: How This Family Spreads INAD Awareness
Have you ever heard of CD55-deficient protein-losing enteropathy? This rare condition, which is also called CHAPLE disease, was only identified in the past 10 years. Right now, there are only…
Continue Reading
FDA Approves Veopoz (Pozelimab) for CHAPLE Disease
source: pixabay.com
When Crystal York learned that her daughter Harmony had a rare genetic disease called DHX30, she was shocked. Even more shocking is that Harmony is just one of 40…
Continue Reading
Family Seeks Service Dog for Daughter with DHX30
source: pixabay.com
Chorea, a characteristic manifestation of Huntington's disease, refers to uncontrolled "dance-like" movements in the fingers, feet, face, or torso. These movements may worsen in times of heightened emotion or…
Continue Reading
FDA Approves INGREZZA for Huntington’s Disease Chorea
source: pixabay.com
At the moment, there are limited treatment options for glioblastoma, a rare form of brain cancer. While surgery, radiation, chemotherapy, and electric-field therapy are all utilized in the fight…
Continue Reading
ICYMI: Gallium Maltolate Earns Orphan Drug Designation for Pediatric Glioblastoma
source: shutterstock.com
The Phase 2 EXHALE-1 clinical trial, initiated by clinical-stage biotechnology company Areteia Therapeutics, Inc. ("Areteia"), sought to understand how safe, effective, and well-tolerated dexpramipexole was in reducing symptoms of…
Continue Reading
Study Results Available on Dexpramipexole for Eosinophilic Asthma
Chronic osteomyelitis in the clavicle. Sourced from: Shannonpercivalsmith / CC BY (https://creativecommons.org/licenses/by/3.0)
For many people, a broken bone would severely interrupt their life. But six-year-old Avery Balcazar has learned to live with it—even when it’s tough. As reported by CBC News, Balcazar…
Continue Reading
OI Has Led to More Than 82 Broken Bones for This 6-Year-Old
When Dr. Niranjana Parthasarathi, M.D., was in medical school at Virginia Commonwealth University (VCU), she still remembers a lesson that changed her life. Her course introduced her to systemic lupus…
Continue Reading
Doctor Writes Book About Personal Experience with Lupus
source: pixabay.com
A Phase 2 clinical study found TAK-994 to be relatively effective in reducing symptoms like excessive daytime sleepiness (EDS) and cataplexy (sudden, uncontrollable muscle weakness often triggered by strong…
Continue Reading
ICYMI: TAK-994 Reduced Sleepiness and Cataplexy in Narcolepsy – But Is It Safe?
Photo courtesy of Amanda Chaffin
Rare Community Profiles Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…
Continue Reading
Rare Community Profiles: Fiercely Advocating for the SMA Community: Why Amanda Will Never Stop Fighting for her Son Kayden
Despite advances in research and the advent of multiple investigational treatments, pancreatic cancer is still incredibly difficult to treat. The five-year survival rate sits at just 12%. Existing therapies…
Continue Reading
MAb-AR20.5 Earns Orphan Drug Designation for Pancreatic Cancer
Actress Francia Raisa is well-known for her roles in Grown-Ish, Bring It On: All Or Nothing, The Secret Life of the American Teenager, and How I Met Your Father. She’s…
Continue Reading
Actress Francia Raisa Shares Her PCOS Experience
When Camille Wahl was a child, she loved Irish step dance. She translated her love physically, becoming a competitive dancer until she was ten years old. It was then, reports…
Continue Reading
In Her 9th Osteosarcoma Relapse, This Young Woman Continues to Fight
Recent results are available from the dose escalation portion of the Phase 1 ANTLER study. In reporting from Targeted Oncology, Jordyn Sava shares that the study included 16 participants living…
Continue Reading
CB-010 Shows Promise for B-Cell Non-Hodgkin Lymphoma, Study Shows
source: pixabay.com
In the United States, the FDA grants Fast Track designation to drugs that treat rare and serious conditions or fill unmet needs. The designation helps to facilitate and expedite the…
Continue Reading
Selinexor Granted Fast Track Designation for Myelofibrosis
source: shutterstock.com
When Christine Todd learned that her kidneys were failing, she was frightened and concerned. Todd has polycystic kidney disease (PKD), an inherited condition characterized by cysts that develop in the…
Continue Reading
Cubs Fan with PKD Goes to Wrigley Field in Search of Kidney Donor
source: pixabay.com
In May 2023, the U.S. Food and Drug Administration (FDA) approved Vyjuvek, a gene therapy, for dystrophic epidermolysis bullosa (DEB). This treatment has brought support to numerous people living with…
Continue Reading
A Novel Formulation of Vyjuvek Helped One Teen with DEB Reclaim His Eyesight
source: pixabay.com
As our understanding of genetics increases, so does our awareness of the multitude of genetic diseases—many of which continue to be discovered to this day. While X-linked lymphoproliferative disease (XLP)…
Continue Reading
Researchers Dive Deeper into Understanding the Ultra-Rare XLP-2
Source: www.pixabay.com
An estimated 25% of children globally are affected by atopic dermatitis; you may known this skin condition by its more colloquial name, "eczema." Often manifesting by five years old, atopic…
Continue Reading
Nemolizumab Reduces Pruritus (Itchiness) in Children with Atopic Dermatitis
In the past, treatment for WHIM syndrome has focused on symptom management: treating infections and myelokathexis with antibiotics or granulocyte colony stimulating factor. Infusion can treat hypogammaglobulinemia and surgery…
Continue Reading
Mavorixafor is Safe and Effective for Treating WHIM Syndrome, Trial Data Suggests
Source: pixabay.com
If you’re looking for drive and determination, look no further. 14-year-old Sophia Nohre is ready to tackle any obstacle in her path—and she does so relentlessly. Her swimming coach, Adam…
Continue Reading
Swimmer with Osteogenesis Imperfecta Wins Gold & Silver at the Hartford Nationals